市場調查報告書

全球胃癌治療市場:2019年∼2025年的預測

Global Gastric Cancer Treatment Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 920458
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球胃癌治療市場:2019年∼2025年的預測 Global Gastric Cancer Treatment Market 2019-2025
出版日期: 2019年03月01日內容資訊: 英文
簡介

全球胃癌治療市場在預測期間內預計將以4.9%的年複合成長率成長。胃癌的技術進步,發生率和盛行率的上升,是推動該市場的成長。

本報告提供全球胃癌治療市場的相關調查,市場機會和趨勢,成長及阻礙因素,各治療、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 報告概要

  • 調查方法與工具
  • 市場分析
    • 各市場區隔
    • 各地區
    • 各利害關係者

第2章 市場概要與洞察

  • 報告的範圍
  • 分析師的洞察及目前市場趨勢
    • 主要調查結果
    • 建議
    • 結論
  • 規則與法規

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • F. Hoffmann-La Roche AG
    • Bristol-Myers Squibb, Co.
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Celltrion, Inc.

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 各類治療
    • 化療
    • 免疫療法
    • 放射線治療
    • 標靶治療
    • 手術
  • 各終端用戶
    • 醫院、診療所
    • 專門的癌症治療中心
    • 其他

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories, Inc.
  • Amgen, Inc.
  • ASLAN Pharmaceuticals Pte., Ltd.
  • AstraZeneca PLC
  • Athenex, Inc.
  • Bristol Myers Squibb, Co.
  • Celgene Corp.
  • Celltrion, Inc.
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • ImmunoGen, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Oncolytics Biotech, Inc.
  • 大塚集團株式會社
  • Pacific Edge, Ltd.
  • Pfizer, Inc.
  • Polaris Pharmaceuticals, Inc.
  • Thermo Fisher Scientific, Inc.
目錄
Product Code: OMR2020081

Global Gastric Cancer Treatment Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy), and by End-User (Hospitals and Clinics, Specialized Cancer Treatment Centres, and Others) and Forecast 2019-2025

Gastric cancer treatment market is expected to grow with a CAGR of 4.9% during the forecast period. The technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the gastric cancer treatment market across the globe. Gastric cancer leads to uncontrolled progress of malignant cells that originate in stomach tissue. The main cause of developing stomach cancer is still not known exactly, however, bacterium Helicobacter Pylori is one of the key causes and also smoking & ulcer are some factors leading to stomach cancer. Other factor included such as age, diet, and stomach disease can affect the risk of developing stomach cancer. Approximately 800,000 cancer-related death is caused by gastric cancer every year, as per World Health Organization.

Stomach cancer is considered as one of the most common cancer across the globe. Symptoms of stomach cancer embrace indigestion and stomach discomfort or pain. Tests that examine the stomach and oesophagus are used to detect and diagnose stomach cancer. About 6 of every 10 people have spotted with stomach cancer each year are 65 or older. The average risk that a person will develop stomach cancer in their lifetime is about 1 in 111. This risk is higher in men than in women and can also be affected by a number of other factors. As the case increasing throughout the globe the market will also increases. According to the National Institute of Cancer, the stomach cancer is common in both men and women. Age, diet and stomach disease, including infection with Helicobacter pylori, can affect the risk of developing stomach cancer. The number of new cases of stomach cancer was 7.3 per 100,000 men and women per year based on 2010-2014 cases.

Research Methodology

The market study of the global gastric cancer treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for the pharmaceutical companies, research institutes, investment companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Gastric Cancer Treatment Market Research and Analysis by Therapy

2. Global Gastric Cancer Treatment Market Research and Analysis by End-User

The Report covers:

  • Comprehensive research methodology of the global gastric cancer treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global gastric cancer treatment market.
  • Insights about market determinants which are stimulating the global gastric cancer treatment market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. F. Hoffmann-La Roche AG
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Bristol-Myers Squibb, Co.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Pfizer, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Merck & Co., Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Celltrion, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Gastric Cancer Treatment Market by Therapy
    • 5.1.1. Chemotherapy
    • 5.1.2. Immunotherapy
    • 5.1.3. Radiation Therapy
    • 5.1.4. Targeted Therapy
    • 5.1.5. Surgery
  • 5.2. Global Gastric Cancer Treatment Market by End-User
    • 5.2.1. Hospitals and Clinics
    • 5.2.2. Specialized Cancer Treatment Centres
    • 5.2.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Amgen, Inc.
  • 7.3. ASLAN Pharmaceuticals Pte., Ltd.
  • 7.4. AstraZeneca PLC
  • 7.5. Athenex, Inc.
  • 7.6. Bristol Myers Squibb, Co.
  • 7.7. Celgene Corp.
  • 7.8. Celltrion, Inc.
  • 7.9. Eli Lilly and Co.
  • 7.10. GlaxoSmithKline PLC
  • 7.11. Hoffmann-La Roche AG
  • 7.12. ImmunoGen, Inc.
  • 7.13. Merck & Co., Inc.
  • 7.14. Novartis AG
  • 7.15. Oncolytics Biotech, Inc.
  • 7.16. Otsuka Holdings Co., Ltd.
  • 7.17. Pacific Edge, Ltd.
  • 7.18. Pfizer, Inc.
  • 7.19. Polaris Pharmaceuticals, Inc.
  • 7.20. Thermo Fisher Scientific, Inc.

List of Tables

  • 1. GLOBAL GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 2. GLOBAL CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL TARGETED THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL GASTRIC CANCER TREATMENT MARKET BY END-USER
  • 8. GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL SPECIALIZED CANCER TREATMENT CENTRES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 12. NORTH AMERICAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. NORTH AMERICAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 14. NORTH AMERICAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 15. EUROPEAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. EUROPEAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 17. EUROPEAN GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 18. ASIA-PACIFIC GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. ASIA-PACIFIC GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 20. ASIA-PACIFIC GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 21. REST OF THE WORLD GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
  • 22. REST OF THE WORLD GASTRIC CANCER TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • List of Figures

  • 1. GLOBAL GASTRIC CANCER TREATMENT MARKET SHARE BY THERAPY, 2018 VS 2025 (%)
  • 2. GLOBAL GASTRIC CANCER TREATMENT MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 3. GLOBAL GASTRIC CANCER TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. The US GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD GASTRIC CANCER TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
Back to Top